New & Noteworthy

Jun 11, 2018
Pharmaceutical Executive
Laboratory testing has become a critical access point for sales teams in the age of personalized medicine, writes Melissa Leonhauser.
May 22, 2018
Pharmaceutical Executive
In its 12th annual feature, Pharm Exec profiles a new round of biopharma products that are making waves in five key areas in healthcare and R&D.
May 14, 2018
Ellen Coleman outlines the highlights of a recent webinar on ensuring that patient advocacy is a key element of a market access strategy.
May 09, 2018
Digital attribution models have transformed the way e-commerce companies measure and optimize ad spend. So why have medical marketers been slow to adopt them, asks Kevin Troyanos.
May 08, 2018
Pharmaceutical Executive
Overcoming the challenges of digital brand management will involve choices in spending and channels.
May 08, 2018
Pharmaceutical Executive
With digitalization enabling patient engagement with their own health experience more than ever before, two critical elements will steer pharma’s advertising path.
May 03, 2018
Despite the uncertainty, there is plenty of work to be done to reduce risk in supply chains ahead of the UK’s exit from the European Union, write Johnathon Marshall and Chris Cartmell.
Apr 26, 2018
Pharmaceutical Executive
Prashant Dhanavade discusses the impact, challenges and the importance of ensuring readiness with ICH E2B (R3) EudraVigilance.
Apr 26, 2018
Graham Francis looks at how increased levels of data integrity and the shift in pharma's organizational culture impacts labeling.
Apr 25, 2018
Pharmaceutical Executive
The way to achieve best patient outcomes for the medical affairs function is true peer-to-peer partnerships with external experts and the medical community, write Alexander Bedenkov, Filip Surmont, and Maarten Beekman.
native1_300x100
lorem ipsum